An advanced imaging method is showing promise as a way to improve the diagnosis of prostate cancer by giving clinicians a clearer view of suspected tumours during biopsy.
A new kind of bone implant reduces the chance of infection, and therefore significantly decreases implant failure rates.
PET/MRI is offering new imaging opportunities for cancer patients at various points along the care pathway with its ability to assess different biological processes and its increased specificity.
‘The combination of nuclear medicine and modern imaging procedures such as CT and MRI is becoming increasingly important in the diagnosis, treatment planning and aftercare of cancerous diseases,’ explains Professor Katrine Åhlström Riklund, who presides over the newly established European Society for Hybrid Medical Imaging, ESHI.
A new world of flexible, bendable, even stretchable electronics is emerging from research labs to address a wide range of potentially game-changing uses.
By implanting electrodes in the brain tissue one can stimulate or capture signals from different areas of the brain. These types of brain implants, or neuro-prostheses as they are sometimes called, are used to treat Parkinson's disease and other neurological diseases.
The last decade saw PET and now PET/CT numbers expand rapidly in Europe. More recently the picture has been less rosy with public and private sectors delaying new projects and pushing back the replacement of equipment.
Late in 2009, GE Healthcare’s 64 slice PET/CT Discovery 690 began its use in the University Clinic for Nuclear Medicine in Innsbruck, Austria. Apart from routine clinical examinations for treatment control via FDG (fluorodeoxyglucose), the scanner is also employed in clinical research - particularly for Gallium 68DOTA PET/CT examination.